We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$384M
1-Year Est. Return
10.32%
This Fund
S&P 500
This Quarter
Est. Return
-0.95%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.99B
AUM Growth
-$235M
(-11%)
Cap. Flow
-$142M
Cap. Flow
% of AUM
-7.12%
Top 10 Holdings %
Top 10 Hldgs %
24.37%
Holding
493
New
58
Increased
236
Reduced
102
Closed
64
Top Buys
| 1 |
Pfizer
PFE
|
+$34.4M |
| 2 |
Assurant
AIZ
|
+$28.5M |
| 3 |
Electronic Arts
EA
|
+$26.1M |
| 4 |
Merck
MRK
|
+$23.9M |
| 5 |
JNPR
Juniper Networks
JNPR
|
+$16.9M |
Top Sells
| 1 |
Netflix
NFLX
|
+$34.6M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$29.1M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$23.9M |
| 4 |
10x Genomics
TXG
|
+$23.8M |
| 5 |
Extra Space Storage
EXR
|
+$22.2M |
Sector Composition
| 1 | Healthcare | 25.99% |
| 2 | Consumer Staples | 23.96% |
| 3 | Consumer Discretionary | 9.04% |
| 4 | Communication Services | 8.47% |
| 5 | Materials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
General Mills
GIS
$20.7B
| $56.7M | 2.85% |
837,855
-141,869
| -14% | -$9.52M |
|
|
2
Pfizer
PFE
$143B
| $53.6M | 2.69% |
1,034,549
+662,610
| +178% | +$34.4M |
|
3
Eli Lilly
LLY
$1.04T
| $52.8M | 2.65% |
184,286
-24,715
| -12% | -$6.36M |
|
4
Gilead Sciences
GILD
$169B
| $47.7M | 2.4% |
802,991
-100,590
| -11% | -$6.43M |
|
5
Clorox
CLX
$11.9B
| $47.2M | 2.37% |
339,345
+24,242
| +8% | +$3.71M |
|
|
K
6
DELISTED
Kellanova
K
| $46.9M | 2.36% |
775,074
-80,253
| -9% | -$4.83M |
|
7
Hormel Foods
HRL
$14.1B
| $45.4M | 2.28% |
881,010
-142,684
| -14% | -$6.99M |
|
8
Dollar Tree
DLTR
$24.7B
| $45M | 2.26% |
281,130
-37,507
| -12% | -$5.31M |
|
9
J.M. Smucker
SJM
$12.2B
| $44.9M | 2.26% |
331,399
-38,586
| -10% | -$5.26M |
|
10
Conagra Brands
CAG
$6.92B
| $44.3M | 2.23% |
1,319,147
-52,801
| -4% | -$1.8M |
|
11
Becton Dickinson
BDX
$44.1B
| $42.7M | 2.15% |
164,606
-11,902
| -7% | -$3.06M |
|
12
Gen Digital
GEN
$16.3B
| $42.5M | 2.14% |
1,604,020
-345,139
| -18% | -$9.49M |
|
13
Campbell Soup
CPB
$6.75B
| $39.4M | 1.98% |
884,894
-137,293
| -13% | -$6.07M |
|
14
Biogen
BIIB
$30.8B
| $37.4M | 1.88% |
177,693
+10,314
| +6% | +$2.24M |
|
15
Newmont
NEM
$97B
| $35.3M | 1.78% |
444,778
-199,289
| -31% | -$13.5M |
|
16
Franco-Nevada
FNV
$38.2B
| $34.5M | 1.73% |
216,485
-51,065
| -19% | -$7.35M |
|
17
Consolidated Edison
ED
$41.4B
| $32.9M | 1.66% |
347,572
-140,450
| -29% | -$12.1M |
|
|
18
Assurant
AIZ
$13.6B
| $31.6M | 1.59% |
+173,906
| New | +$28.5M |
|
19
Domino's
DPZ
$11B
| $31.5M | 1.58% |
77,398
-21,479
| -22% | -$9.37M |
|
20
C.H. Robinson
CHRW
$24.3B
| $30M | 1.51% |
278,396
-25,747
| -8% | -$2.62M |
|
21
Kroger
KR
$35.9B
| $29.7M | 1.49% |
517,051
-139,769
| -21% | -$6.94M |
|
|
22
Merck
MRK
$315B
| $29.4M | 1.48% |
358,736
+303,285
| +547% | +$23.9M |
|
23
Lumen
LUMN
$6.5B
| $27.3M | 1.37% |
2,418,874
+282,365
| +13% | +$3.23M |
|
24
Regency Centers
REG
$15.1B
| $26.8M | 1.35% |
376,123
-101,053
| -21% | -$7.07M |
|
25
Moderna
MRNA
$25.1B
| $26.6M | 1.34% |
154,177
+60,818
| +65% | +$10.2M |
|
Similar funds
PCM
DFA
BAMG
DR
GCP
DC
GA
VI
TOBAM's Q1 2022 Portfolio in Review
As of Q1 2022, TOBAM held 493 positions worth $1.99B, down 11% from $2.22B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
TOBAM withdrew a net $142M in Q1 2022, closing 64 positions and reducing 102 holdings. Its most notable exit was Citrix Systems Inc, an estimated $29.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 22% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, TOBAM opened a new position in Assurant worth $31.6M.
- TOBAM's largest Q1 2022 buy was Assurant: 173,906 shares worth $31.6M.
- TOBAM added most to Pfizer in Q1 2022, an estimated $34.4M increase.
- TOBAM's biggest Q1 2022 reduction was Netflix, cutting an estimated $34.6M.
- TOBAM fully exited Citrix Systems Inc in Q1 2022, selling an estimated $29.1M.
- TOBAM's ten largest holdings make up 24% of its $1.99B portfolio in Q1 2022.
- TOBAM opened 58 new positions and closed 64 in Q1 2022.
- TOBAM's portfolio value fell 11% quarter-over-quarter to $1.99B.
Based on TOBAM's 13F filing for Q1 2022, filed 25 Apr 2022.